mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |